i n f l a r x

Loading

Press Release

Home Investors Press Releases Press Release

InflaRx Receives FDA Emergency Use Authorization for Gohibic (vilobelimab) for Treatment of Critically Ill COVID-19 Patients

Apr 04, 2023

Time to read 4 Minutes

Download PDF

Back